Speech-Language Pathologists in Genoa, OH Accepting Medicare

3 Speech-Language Pathologists found. Showing 1 - 3

Judith Reichert Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2820 N Genoa Clay Center Rd, Genoa, OH 43430 Phone: 419-855-7741

Mrs. Denise Mitchell Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 2766 N Genoa Clay Center Rd, Genoa, OH 43430 Phone: 419-855-7564

Adam Schlagheck Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 21080 W Holts East Rd, Genoa, OH 43430 Phone: 419-260-8525

News Archive

SeqWright deploys Isilon scale-out NAS storage solution for next-generation genomic sequencing services

Isilon® Systems today announced that SeqWright has deployed Isilon scale-out NAS as an end-to-end storage solution for its full range of next-generation genomic sequencing services. By combining Isilon's X-Series, NL-Series and Backup Accelerator, SeqWright has created a comprehensive solution for every stage of its DNA sequencing workflow – from primary storage, to nearline archival, to tape backup – accelerating time-to-results without requiring full-time storage administration.

Can-Fite BioPharma receives Australian and Chinese patents for new drug to treat erectile dysfunction

Can-Fite BioPharma Ltd., a biotechnology company advancing a pipeline of proprietary small molecule drugs that address liver diseases, inflammatory diseases and sexual dysfunction, today announced that the Australian and Chinese patent offices have granted the Company a patent for the utilization of A3 adenosine receptor ligands in the treatment of sexual dysfunction, in a patent (Australian, No. 2013301125ZL, Chinese No. 2013800472970) titled, "A3 adenosine receptor ligands for use in treatment of a sexual dysfunction."

Significant benefits in non-small-cell lung cancer from customizing erlotinib treatment

Lung cancer patients whose tumors carry specific genetic mutations can achieve significantly longer survival when treated with targeted therapies such as erlotinib, Spanish researchers report.

Study finds higher incidence of physical intimate partner violence during COVID-19

There was a higher incidence and severity of physical intimate partner violence (IPV) among patients seen at a large, academic medical center in the U.S. during the COVID-19 pandemic compared with the prior three years, according to a new study published in Radiology.

Elafin protein protects against inflammatory diseases

This protection is provided by a human protein, Elafin, which is artificially introduced into dairy produce bacteria (Lactococcus lactis and Lactobacillus casei). In time, this discovery could be useful for individuals suffering from chronic inflammatory diseases such as Crohn's disease or ulcerative colitis.

Read more Medical News

› Verified 3 days ago